Design of a series of bicyclic HIV-1 integrase inhibitors. Part 1: Selection of the scaffold

被引：36

作者：

Jones, Eric D. ^{[1
]}

Vandegraaff, Nick ^{[1
]}

Le, Giang ^{[1
]}

Choi, Neil ^{[1
]}

Issa, William ^{[1
]}

Macfarlane, Katherine ^{[1
]}

Thienthong, Neeranat ^{[1
]}

Winfield, Lisa J. ^{[1
]}

Coates, Jonathan A. V. ^{[1
]}

Lu, Long ^{[2
]}

Li, Xinming ^{[2
]}

Feng, Xiao ^{[2
]}

Yu, Changjiang ^{[2
]}

Rhodes, David I. ^{[1
]}

Deadman, John J. ^{[1
]}

机构：

[1] Avexa Ltd, Richmond, Vic 3121, Australia

[2] Chinese Acad Sci, Shanghai Inst Organ Chem, Shanghai 200032, Peoples R China

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2010年 / 20卷 / 19期

关键词：

Integrase; Inhibitor; Synthesis; 3-Hydroxy-pyrido[12-a]pyrimidin-4-one;

D O I：

10.1016/j.bmcl.2010.07.079

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

HIV integrase inhibitors based on a novel bicyclic pyrimidinone core is presented. Nine variations of the core scaffold are evaluated leading to optimization of the 6:6 core giving compound 48 with an EC50 of 3 nM against wild type HIV infected T-cells. (C) 2010 Elsevier Ltd. All rights reserved.

引用

页码：5913 / 5917

页数：5

共 50 条

[41] De novo design based identification of potential HIV-1 integrase inhibitors: A pharmacoinformatics study
Shinde, Pooja Balasaheb
Bhowmick, Shovonlal
Alfantoukh, Etidal
Patil, Pritee Chunarkar
Wabaidur, Saikh Mohammad
Chikhale, Rupesh, V
Islam, Md Ataul
COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2020, 88 (88)
[42] HIV-1 integrase strand-transfer inhibitors: Design, synthesis and molecular modeling investigation
De Luca, Laura
De Grazia, Sara
Ferro, Stefania
Gitto, Rosaria
Christ, Frauke
Debyser, Zeger
Chimirri, Alba
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (02) : 756 - 764
[43] HIV-1 integrase inhibition of biscoumarin analogues
Su, Chang-Xiao
Mouscadet, Jean-Francois
Chiang, Chih-Chia
Tsai, Hou-Jen
Hsu, Ling-Yih
CHEMICAL & PHARMACEUTICAL BULLETIN, 2006, 54 (05) : 682 - 686
[44] Computational screening of inhibitors for HIV-1 integrase using a receptor based pharmacophore model
Jaganatharaja, Janani
Gowthaman, Ragul
BIOINFORMATION, 2006, 1 (04) : 112 - 117
[45] Dihydroxypyridopyrazine-1,6-dione HIV-1 integrase inhibitors
Wai, John S.
Kim, Boyoung
Fisher, Thorsten E.
Zhuang, Linghang
Embrey, Mark W.
Williams, Peter D.
Staas, Donnette D.
Culberson, Chris
Lyle, Terry A.
Vacca, Joseph P.
Hazuda, Darla J.
Felock, Peter J.
Schleif, William A.
Gabryelski, Lori J.
Jin, Lixia
Chen, I-Wu
Ellis, Joan D.
Mallai, Rama
Young, Steven D.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (20) : 5595 - 5599
[46] Progress in HIV-1 Integrase Inhibitors: A Review of their Chemical Structure Diversity
Hajimahdi, Zahra
Zarghi, Afshin
IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2016, 15 (04): : 595 - 628
[47] Synthesis and Biological Activities of Quinoline Derivatives as HIV-1 Integrase Inhibitors
Luo Zai-gang
Zeng Cheng-chu
Wang Fang
He Hong-qiu
Wang Cun-xin
Du Hong-guang
Hu Li-ming
CHEMICAL RESEARCH IN CHINESE UNIVERSITIES, 2009, 25 (06) : 841 - 845
[48] New developments in diketo-containing inhibitors of HIV-1 integrase
Zhao, Guisen
Wang, Chao
Liu, Chuan
Lou, Hongxiang
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2007, 7 (07) : 707 - 725
[49] Synthesis and Biological Activities of Quinoline Derivatives as HIV-1 Integrase Inhibitors
LUO Zai-gang1
2. College of Science
Chemical Research in Chinese Universities, 2009, 25 (06) : 841 - 845
[50] Subtype Diversity Associated with the Development of HIV-1 Resistance to Integrase Inhibitors
Brenner, Bluma G.
Lowe, Matthew
Moisi, Daniela
Hardy, Isabelle
Gagnon, Simon
Charest, Hugues
Baril, Jean Guy
Wainberg, Mark A.
Roger, Michel
JOURNAL OF MEDICAL VIROLOGY, 2011, 83 (05) : 751 - 759

← 1 2 3 4 5 →